How eCOAs Can Benefit Clinical Trials

Clinical outcome assessments (COAs) are designed to enhance the development of new treatments by facilitating a greater understanding of how a patient functions, feels, and survives. Historically, COAs have been completed with paper and pencil, and typically required participants to travel onsite.
Electronic clinical outcome assessments (eCOAs), however, can be recorded either onsite or remotely on an electronic device, such as a smartphone, tablet, laptop, or desktop computer, which means that data can now be reported at defined time points outside of the clinical environment. This gives researchers a more well-rounded understanding of a treatment’s value and adds new data to better assess health related quality of life impacts that patients often highly value
Read on to learn how the built-in flexibility and freedom of eCOAs can enhance many aspects of a clinical trial.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.